The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 4,301–4,400 of 31,469
Fructose-Rich Beverage Intake and Central Adiposity, Uric Acid, and Pediatric Insulin Resistance
Lin, W., Chan, T., Huang, H., Lee, C., Tsai, S., Wu, P., Wang, T., Wang, T., & Lee, C. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.12.061 · Cited by 82
Pont, F., Duvillard, L., Florentin, E., Gambert, P., & Vergès, B. L. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802070 · Cited by 79
Sundaram, S. S., Halbower, A. C., Pan, Z., Robbins, K. N., Capocelli, K. E., Klawitter, J., Shearn, C. T., & Sokol, R. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.010 · Cited by 79
YANG, Z. K., Yan, C., Liu, G., Niu, Y., Zhang, W., Lu, S., Li, X., Zhang, H., Ning, G., Fan, J., et al. (2016) · Scientific Reports · doi:10.1038/srep37288 · Cited by 79
Sleep characteristics and inflammatory biomarkers among midlife women
Nowakowski, S., Matthews, K. A., von Känel, R., Hall, M. H., & Thurston, R. C. (2018) · SLEEP · doi:10.1093/sleep/zsy049 · Cited by 80
Piatti, P. M., Monti, L. D., Galli, L., et al. (2000) · Metabolism · doi:10.1053/meta.2000.6257 · Cited by 79
Rasmussen, S., Urhammer, S., Berglund, L., Jensen, J., Hansen, L., Echwald, S., Borch-Johnsen, K., Horikawa, Y., Mashima, H., Lithell, H., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3561 · Cited by 86
Jiskoot, G., Dietz de Loos, A., Beerthuizen, A., Timman, R., Busschbach, J., & Laven, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233876 · Cited by 76
“Homeostatic assessment of insulin resistance (HOMA-IR) was calculated from fasting insulin and glucose by the following equation: HOMA-IR = (fasting glucose (mg/dl) � fasting insulin (μIU/ml)) / 405 [39].”
MethodWolf, R. M., Steele, K. E., Frame, L. A., Magnuson, T. H., Schweitzer, M., & Wong, G. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133955 · Cited by 76
Specht, B. J., Wadwa, R. P., Snell‐Bergeon, J. K., Nadeau, K. J., Bishop, F. K., & Maahs, D. M. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.07.036 · Cited by 77
Dietary Patterns, Metabolic Markers and Subjective Sleep Measures in Resident Physicians
Mota, M. C., De-Souza, D. A., Rossato, L. T., Silva, C. M., Araújo, M. B. J., Tufik, S., de Mello, M. T., & Crispim, C. A. (2013) · Chronobiology International · doi:10.3109/07420528.2013.796966 · Cited by 87
Park, S. Y., Park, S. E., Jung, S. W., Jin, H., Park, I. B., Ahn, S. V., & Lee, S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13345 · Cited by 78
Pekgör, S., Duran, C., Berberoğlu, U., & Eryılmaz, M. A. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0005 · Cited by 78
Corcoy, R., Mendoza, L. C., Simmons, D. S., Desoyé, G., Adelantado, J. M., Chico, A. I., Devlieger, R., Assche, A. V., Galjaard, S., Timmerman, D., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.04.006 · Cited by 81
Kitamura, H. (2019) · Molecules · doi:10.3390/molecules24234394 · Cited by 86
Gut microbiota is associated with metabolic health in children with obesity
Alcazar, M., Escribano, J., Ferré, N., Closa-Monasterolo, R., Selma‐Royo, M., Feliu, A., Castillejo, G., Luque, V., Closa-Monasterolo, R., Escribano, J., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.06.007 · Cited by 84
Luo, P., Cao, Y., Li, P., Li, W., Song, Z. J., Fu, Z., Zhou, H., Yi, X., Zhu, L., & Zhu, S. (2022) · Medicina · doi:10.3390/medicina58070876 · Cited by 86
Exposure to per- and polyfluoroalkyl substances (PFAS) and type 2 diabetes risk
Roth, K., & Petriello, M. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.965384 · Cited by 78
Song, J., Li, Y., Zhu, J., Liang, J., Xue, S., & Zhu, Z. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1341828 · Cited by 80
Obesity, insulin resistance and the prevalence of atopy and asthma in US adults
Ma, J., Xiao, L., & Knowles, S. B. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02402.x · Cited by 81
Insulin resistance and metabolic syndrome in prepubertal boys with Klinefelter syndrome
Bardsley, M. Z., Falkner, B. E., Kowal, K., & ROSS, J. L. (2011) · Acta Paediatrica · doi:10.1111/j.1651-2227.2011.02161.x · Cited by 77
Effects of exercise‐induced weight loss on acylated and unacylated ghrelin in overweight children
Kim, H. J., Lee, S. Y., Kim, T. W., Kim, H. H., Jeon, T. Y., Yoon, Y. S., Oh, S. W., Kwak, H. M., & Lee, J. G. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03058.x · Cited by 80
Effects of diet and exercise on metabolic disturbances in high-fat diet-fed mice
Vieira‐Potter, V. J., Valentine, R. J., Wilund, K. R., & Woods, J. A. (2009) · Cytokine · doi:10.1016/j.cyto.2009.03.006 · Cited by 78
Lubrano, C., Saponara, M., Bárbaro, G., Specchia, P., Addessi, E., Costantini, D., Tenuta, M., Lorenzo, G. D., Genovesi, G., Donini, L. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047059 · Cited by 81
Zinc Transporter-8 Gene (SLC30A8) Is Associated with Type 2 Diabetes in Chinese
Xiang, J., Li, X.-Y., Xu, M., Hong, J., Huang, Y., Tan, J., Lu, X., Dai, M., Yu, B., & Ning, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0161 · Cited by 77
Woo, H., Kim, K. H., Rhee, E., Park, H., & Lee, M. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0055 · Cited by 78
Adiposity and Glycemic Control in Children Exposed to Perfluorinated Compounds
Timmermann, C. A. G., Rossing, L. I., Grøntved, A., Ried‐Larsen, M., Dalgård, C., Andersen, L. B., Grandjean, P., Nielsen, F., Svendsen, K. D., Scheike, T., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3460 · Cited by 81
Tai, E., Lau, T., Ho, S., Fok, A. C. K., & Tan, C. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801220 · Cited by 78
The Relationship Between Insulin Sensitivity and Serum Adiponectin Levels in Three Population Groups
Ferris, W. F., Naran, N. H., Crowther, N. J., Rheeder, P., van der Merwe, L., & Chetty, N. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-870580 · Cited by 78
Forlani, G., Bonito, P. D., Mannucci, E., Capaldo, B., Genovese, S., Orrasch, M., Scaldaferri, L., Bartolo, P. D., Melandri, P., Dei, A., et al. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345581 · Cited by 78
Saucedo, R., Zárate, A., Basurto, L., Hernández, M., Puello, E., Galván, R. E., & Campos, S. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.06.009 · Cited by 78
Orellana, M. D., Rodrigo, R., Varela, N., Araya, J., PONIACHIK, J., Csendes, A., Smok, G., & Videla, L. A. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.10.001 · Cited by 78
Derangement of glucose metabolism in hyperparathyroidism
Massimo, P., & Borretta, G. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345264 · Cited by 78
Numao, S., Kawano, H., Endo, N., Yamada, Y., Konishi, M., Takahashi, M., & Sakamoto, S. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.58 · Cited by 78
Apostolidou, M., Alexopoulos, E. Ι., Damani, E., Liakos, N., Chaidas, K., Boultadakis, E., Apostolidis, T., Gourgoulianis, K. I., & Kaditis, A. G. (2008) · Pediatric Pulmonology · doi:10.1002/ppul.20808 · Cited by 78
A High Legume Low Glycemic Index Diet Improves Serum Lipid Profiles in Men
Zhang, Z., Lanza, E., Kris‐Etherton, P. M., Colburn, N. H., Bagshaw, D., Rovine, M. J., Ulbrecht, J. S., Bobe, G., Chapkin, R. S., & Hartman, T. J. (2010) · Lipids · doi:10.1007/s11745-010-3463-7 · Cited by 87
Bastard, J., Vandernotte, J.-M., Faraj, M., Karelis, A. D., Messier, L., Malita, F. M., Garrel, D. R., Prud’homme, D., & RABASA-LHORET, R. P. R. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.02.004 · Cited by 78
Ollikainen, M., Ismail, K., Gervin, K., Kyllönen, A., Hakkarainen, A., Lundbom, J., Järvinen, E., Harris, J. R., Lundbom, N. M. I., Rissanen, A., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0073-5 · Cited by 80
Demirel, F., Bıdecı, A., Cınaz, P., Çamurdan, M. O., Biberoğlu, G., Yeşilkaya, E., & Hasanoğlu, A. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02849.x · Cited by 78
Kelishadi, R., Hashemipour, M., Mohammadifard, N., Alikhasi, H., & Adeli, K. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03220.x · Cited by 78
Derosa, G., Cicero, A. F. G., D’Angelo, A., Ragonesi, P. D., Ciccarelli, L., Piccinni, M. N., PRICOLO, F., SALVADEO, S. A. T., Ferrari, I., Gravina, A., et al. (2006) · Hypertension Research · doi:10.1291/hypres.29.849 · Cited by 78
Lacroix, M., Kina, E., & Hivert, M. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0360-x · Cited by 78
Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis
Yoo, H.-G., Lee, S., Chae, H., et al. (2009) · Rheumatology International · doi:10.1007/s00296-009-1304-x · Cited by 78
Buqué, X., Martínez, M. J., Cano, A., Miquilena-Colina, M. E., García‐Monzón, C., Aspichueta, P., & Ochoa, B. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m001966 · Cited by 78
Hermansen, K., Hansen, B., Jacobsen, R., Clausen, P., Dalgaard, M., Dinesen, B., Holst, J. J., Pedersen, E. B., & Astrup, A. V. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602151 · Cited by 79
Venojärvi, M., Wasenius, N., Manderoos, S., Heinonen, O. J., Hernelahti, M., Lindholm, H. J., Surakka, J., Lindström, J., Aunola, S., Atalay, M., et al. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.727020 · Cited by 81
The Severity of Menstrual Dysfunction as a Predictor of Insulin Resistance in PCOS
Brower, M. A., Brennan, K., Pall, M., & Azziz, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2815 · Cited by 79
Pérez‐Martínez, L., Pérez‐Matute, P., Aguilera‐Lizarraga, J., Rubio-Mediavilla, S., Narro-Íñiguez, J., Recio, E., Ochoa‐Callejero, L., Oteo, J. A., & Blanco, J. R. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku071 · Cited by 76
Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer
Kalinsky, K. M., Crew, K. D., Refice, S., Xiao, T., Wang, A., Feldman, S. M., Taback, B., Ahmad, A., Cremers, S., Hibshoosh, H. H., et al. (2014) · Cancer Investigation · doi:10.3109/07357907.2014.889706 · Cited by 79
Harrison, M., O'Gorman, D., Mccaffrey, N., Hamilton, M., Zderic, T., Carson, B., & Moyna, N. (2009) · Journal of applied physiology · doi:10.1152/japplphysiol.91367.2008 · Cited by 92
Zuniga, Y. L. M., Rebello, S. A., Oi, P. L., Zheng, H., Lee, J., Tai, E. S., & van Dam, R. M. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513003486 · Cited by 79
Grau, K., Cauchi, S., Holst, C., Astrup, A. V., Martínez, J. A., Saris, W. H. M., Blaak, E. E., Oppert, J., Arner, P., Rössner, S., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27947 · Cited by 77
Mansikkaniemi, K., Juonala, M., TAIMELA, S. P., Hirvensalo, M. H., Telama, R., Huupponen, R., Saarikoski, L. A., Hurme, M., Mallat, Z., Bénessiano, J., et al. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.590146 · Cited by 82
Jiang, Y., Owei, I., Wan, J. Y., Ebenibo, S., & Dagogo-Jack, S. E. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000194 · Cited by 85
Uç, A., Olivier, A. K., Griffin, M. A., Meyerholz, D. K., Yao, J., Abu‐El‐Haija, M. A., Buchanan, K. M., Calderón, O. G. V., Haija, M. A. E., Pezzulo, A. A., et al. (2014) · Clinical Science · doi:10.1042/cs20140059 · Cited by 77
Argilés, J. M. A., Betancourt, A., Guàrdia‐Olmos, J., Peró, M., López-Soriano, F. J., Madeddu, C., Serpe, R., & Busquets, S. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00092 · Cited by 79
Qi, G., Mi, Y., Liu, Z., Fan, R., Qiao, Q., Sun, Y., Ren, B., & Liu, X. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.04.031 · Cited by 81
Insulin Resistance, Prediabetes, Metabolic Syndrome: What Should Every Pediatrician Know?
Ighbariya, A., & Weiss, R. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.2017.s005 · Cited by 78
Tangvarasittichai, S., Pongthaisong, S., & Tangvarasittichai, O. (2015) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-015-0514-0 · Cited by 78
Hannukainen, J. C., Nuutila, P., Borra, R., Kaprio, J. A., Kujala, U. M., Janatuinen, T., Heinonen, O. J., Kapanen, J., Viljanen, T., Haaparanta, M., et al. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.121368 · Cited by 78
Plasma Adiponectin Levels and Blood Pressures in Nondiabetic Adolescent Females
Huang, K., Chen, C., Chuang, L., Ho, S., Tai, T., & Yang, W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030158 · Cited by 78
Ioannou, G. N., Weiss, N. S., Boyko, E. J., Kahn, S. E., & Lee, S. P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.004 · Cited by 78
Adiponectin, insulin resistance, and C-reactive protein in postpubertal Asian Indian adolescents
Vikram, N. K., Misra, A., Pandey, R. M., Dwivedi, M., & Luthra, K. (2004) · Metabolism · doi:10.1016/j.metabol.2004.05.010 · Cited by 78
Variation in the Calpain-10 Gene Affects Blood Glucose Levels in the British Population
Lynn, S., Evans, J., White, C., Frayling, T. M., Hattersley, A. T., Turnbull, D. M., Horikawa, Y., Cox, N. J., Bell, G. I., & Walker, M. (2002) · Diabetes · doi:10.2337/diabetes.51.1.247 · Cited by 78
Al-Awwadi, N. A., Bornet, A., Azay, J., Araiz, C., Delbosc, S., Cristol, J., Linck, N., Cros, G. H., & Teissèdre, P. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf049295g · Cited by 78
Zinc supplementation for the prevention of type 2 diabetes mellitus
Beletate, V., Dib, R. E., & Atallah, Á. N. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005525.pub2 · Cited by 78
A rodent model of rapid-onset diabetes (ROD) induced by glucocorticoids and high-fat feeding
Shpilberg, Y., Beaudry, J. L., D'Souza, A., Campbell, J. E., Peckett, A., & Riddell, M. C. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.008912 · Cited by 77
Yilmaz, M., Biri, A., Karakoç, A., Törüner, F., Bingöl, B., Çakir, N., Tiras, B., Ayvaz, G., & Arslan, M. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345339 · Cited by 77
The role of peptide YY in regulating glucose homeostasis
Boey, D., Sainsbury, A., & Herzog, H. (2007) · Peptides · doi:10.1016/j.peptides.2006.07.031 · Cited by 77
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study
Tagliaferri, V., Romualdi, D., Scarinci, E., De Cicco, S., Di Florio, C., Immediata, V., Tropea, A., Santarsiero, C. M., Lanzone, A., & Apa, R. (2018) · Reproductive Sciences · doi:10.1177/1933719117711262 · Cited by 87
Saito, I., Hitsumoto, S., Maruyama, K., Nishida, W., Eguchi, E., Kato, T., Kawamura, R., Takata, Y., Onuma, H., Osawa, H., et al. (2015) · Journal of Epidemiology · doi:10.2188/jea.je20140254 · Cited by 77
Sharma, A. K., Bharti, S., Goyal, S. N., Arora, S., Nepal, S., Kishore, K., Joshi, S., Kumari, S., & Arya, D. S. (2011) · Phytotherapy Research · doi:10.1002/ptr.3442 · Cited by 77
Lee, W.-J., Chong, K., Chen, C.-Y., Chen, S. C., Lee, Y. C., Ser, K., & Chuang, L. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0401-6 · Cited by 77
Goldberg, R., Temprosa, M., Otvos, J., Brunzell, J., Marcovina, S., Mather, K., Arakaki, R., Watson, K., Horton, E., & Barrett-Connor, E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1452 · Cited by 74
Rasekhi, H., Karandish, M., Jalali, M. T., Mohammadshahi, M., Zarei, M., Saki, A., & Shahbazian, H. B. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-014-0127-9 · Cited by 78
Han, S., Jiao, J., Zhang, W., Xu, J., Wan, Z., Zhang, W., Gao, X., & Qin, L. (2015) · Scientific Reports · doi:10.1038/srep15256 · Cited by 77
van der Aa, M. P., Elst, M. A. J., van de Garde, E. M. W., van Mil, E., Knibbe, C. A. J., & van der Vorst, M. M. J. (2016) · Nutrition and Diabetes · doi:10.1038/nutd.2016.37 · Cited by 77
Amiri, H. L., Agah, S., Azar, J. T., Hosseini, S., Shidfar, F., & Mousavi, S. N. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.09.020 · Cited by 79
Moulton, C. D., Hopkins, C. W. P., Ismail, K., & Stahl, D. R. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.010 · Cited by 81
Nakagomi, A., Sunami, Y., Kawasaki, Y., Fujisawa, T., & Kobayashi, Y. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107442 · Cited by 79
Omura‐Ohata, Y., Son, C., Makino, H., Koezuka, R., Tochiya, M., Tamanaha, T., Kishimoto, I., & Hosoda, K. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0941-y · Cited by 77
Tarantino, G., Citro, V., Balsano, C., & Capone, D. (2020) · Diagnostics · doi:10.3390/diagnostics10060395 · Cited by 77
D’Abbondanza, M., Ministrini, S., Pucci, G., Migliola, E. N., Martorelli, E. E., Gandolfo, V. B., Siepi, D., Lupattelli, G., & Vaudo, G. (2020) · Nutrients · doi:10.3390/nu12092748 · Cited by 81
Miller, V. J., LaFountain, R. A., Barnhart, E. C., Sapper, T. N., Short, J. A., Arnold, W. D., Hyde, P. N., Crabtree, C. D., Kackley, M. L., Kraemer, W. J., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00305.2020 · Cited by 85
Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension
Zhong, H., Zeng, H.-L., Cai, Y.-L., Zhuang, Y.-P., Liou, Y., Wu, Q., & He, X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.679624 · Cited by 79
Chronic lead exposure induces fatty liver disease associated with the variations of gut microbiota
Wan, H., Wang, Y., Zhang, H., Zhang, K., Chen, Y., Chen, C., Zhang, W., Xia, F., Wang, N., & Lu, Y. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113257 · Cited by 77
Trimethoprim–metformin interaction and its genetic modulation by OCT 2 and MATE1 transporters
Grün, B., Kießling, M. K., Burhenne, J., Riedel, K., Weiß, J., Rauch, G., Haefeli, W. E., & Czock, D. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12079 · Cited by 77
HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients
Annema, W., Dikkers, A., de Boer, J. F., Dullaart, R. P. F., Sanders, J., Bakker, S. J. L., & Tietge, U. J. F. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014090857 · Cited by 79
Obesity is associated with activated and insulin resistant immune cells
Viardot, A., Heilbronn, L. K., Samocha‐Bonet, D., Mackay, F., Campbell, L. V., & Samaras, K. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2302 · Cited by 77
Younossi, Z. M., Zheng, L., Stepanova, M., Venkatesan, C., & Mir, H. M. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12265 · Cited by 75
Meier, J. J., Gallwitz, B., Askenas, M., Vollmer, K., Deacon, C. F., Holst, J. J., Schmidt, W. E., & Nauck, M. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1863-7 · Cited by 77
Almeida, A. D. M., Cotrim, H. P., Santos, A. S., et al. (2008) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.12.006 · Cited by 77
Adipocyte fatty acid–binding protein in obese children before and after weight loss
Reinehr, T., Stoffel‐Wagner, B., & Roth, C. L. (2007) · Metabolism · doi:10.1016/j.metabol.2007.07.019 · Cited by 77
Characterization of Insulin Secretion in Valproate‐treated Patients with Epilepsy
Pylvänen, V., Pakarinen, A., Knip, M., & Isojärvi, J. I. T. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00546.x · Cited by 77
Sharma, A. K., Bharti, S., Kumar, R., Krishnamurthy, B., Bhatia, J., Kumari, S., & Arya, D. S. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11184fp · Cited by 81
Ambrosi, B., Masserini, B., Iorio, L., Delnevo, A., Malavazos, A. E., Morricone, L. F., Sburlati, L. F., & Orsi, E. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346663 · Cited by 77
Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients
Takahashi, N., Nakagawa, M., Saikawa, T., Ooie, T., Yufu, K., Shigematsu, S., Hara, M., Sakino, H., Katsuragi, I., Okeda, T., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01363-8 · Cited by 77
Chen, C., Li, T., Li, C.-I., Liu, C.-S., Lin, W., Wu, M., Lai, M.-M., & Lin, C. (2007) · Metabolism · doi:10.1016/j.metabol.2007.04.018 · Cited by 77
Esteghamati, A., Ashraf, H., Esteghamati, A.-R., Meysamie, A., Khalilzadeh, O., Nakhjavani, M., & Abbasi, M. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.03.005 · Cited by 77
Stovall, D. W., Bailey, A. P., & Pastore, L. M. (2010) · Journal of Women s Health · doi:10.1089/jwh.2010.2053 · Cited by 77
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
